Patient-Centered Transformation in Federally Qualified Health Centers in Florida
October 11, 2016, 10am-11am, ET
Presented by Dr. Jeffrey Harman
Professor, Florida State University College of Medicine
Patient-centered practice transformation, such as the Patient Centered Medical Home (PCMH) model, has been identified as an important tool for improving the method of care delivery. Evidence shows that the PCMH model results in reduced costs and use of unnecessary services in primary care practices, however, little is known about its impact on outcomes for the nation’s Federally Qualified Health Centers (FQHC) population.
Dr. Harman will present results of a study that assessed the impact of PCMH transformation in FQHCs on clinical outcomes of patients with diabetes, and discuss a current proposal to evaluate implementation of the PCMH model among 48 FQHC clinic sites in Florida.
HIV-1 Tat protein: sufficient to cause HIV-Associated Neurological Deficits (HAND)
November 8, 2016, 10am-11am, ET
Presented by Dr. Jay McLaughlin
Associate Professor, University of Florida College of Pharmacy
Dr. McLaughlin will discuss data collected from research on the HIV regulatory protein, Tat, using transgenic mice. Findings will demonstrate the ability of Tat protein by itself to produce neurological effects characteristic of HIV-Associated Neurological Deficits (HAND), specifically increased drug seeking behaviors, decreased cognitive abilities, and the onset of mood disorders. Testing results with both novel and clinically approved pharmaceutics suggest potentially new therapeutic approaches to prevent Tat protein related deficits.